Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 3
1989 1
1990 4
1991 3
1992 2
1993 8
1994 6
1995 5
1996 4
1997 1
1998 3
1999 5
2000 7
2001 3
2002 3
2003 3
2004 3
2005 5
2006 7
2007 7
2008 5
2009 1
2010 2
2011 11
2012 8
2013 6
2014 3
2015 9
2016 15
2017 5
2018 8
2019 6
2020 4
2021 9
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

171 results

Results by year

Filters applied: . Clear all
Page 1
Phenotypic signatures of immune selection in HIV-1 reservoir cells.
Sun W, Gao C, Hartana CA, Osborn MR, Einkauf KB, Lian X, Bone B, Bonheur N, Chun TW, Rosenberg ES, Walker BD, Yu XG, Lichterfeld M. Sun W, et al. Nature. 2023 Feb;614(7947):309-317. doi: 10.1038/s41586-022-05538-8. Epub 2023 Jan 4. Nature. 2023. PMID: 36599977 Free PMC article.
Prolonged viral suppression with anti-HIV-1 antibody therapy.
Gaebler C, Nogueira L, Stoffel E, Oliveira TY, Breton G, Millard KG, Turroja M, Butler A, Ramos V, Seaman MS, Reeves JD, Petroupoulos CJ, Shimeliovich I, Gazumyan A, Jiang CS, Jilg N, Scheid JF, Gandhi R, Walker BD, Sneller MC, Fauci A, Chun TW, Caskey M, Nussenzweig MC. Gaebler C, et al. Nature. 2022 Jun;606(7913):368-374. doi: 10.1038/s41586-022-04597-1. Epub 2022 Apr 13. Nature. 2022. PMID: 35418681 Free PMC article.
Targeting the Latent Reservoir for HIV-1.
Sengupta S, Siliciano RF. Sengupta S, et al. Immunity. 2018 May 15;48(5):872-895. doi: 10.1016/j.immuni.2018.04.030. Immunity. 2018. PMID: 29768175 Free PMC article. Review.
HIV reservoirs: what, where and how to target them.
Churchill MJ, Deeks SG, Margolis DM, Siliciano RF, Swanstrom R. Churchill MJ, et al. Nat Rev Microbiol. 2016 Jan;14(1):55-60. doi: 10.1038/nrmicro.2015.5. Epub 2015 Nov 30. Nat Rev Microbiol. 2016. PMID: 26616417 Review.
Selection of epigenetically privileged HIV-1 proviruses during treatment with panobinostat and interferon-α2a.
Armani-Tourret M, Gao C, Hartana CA, Sun W, Carrere L, Vela L, Hochroth A, Bellefroid M, Sbrolla A, Shea K, Flynn T, Roseto I, Rassadkina Y, Lee C, Giguel F, Malhotra R, Bushman FD, Gandhi RT, Yu XG, Kuritzkes DR, Lichterfeld M. Armani-Tourret M, et al. Cell. 2024 Feb 29;187(5):1238-1254.e14. doi: 10.1016/j.cell.2024.01.037. Epub 2024 Feb 17. Cell. 2024. PMID: 38367616 Free PMC article. Clinical Trial.
HIV reservoirs: the new frontier.
Iglesias-Ussel MD, Romerio F. Iglesias-Ussel MD, et al. AIDS Rev. 2011 Jan-Mar;13(1):13-29. AIDS Rev. 2011. PMID: 21412386 Review.
Confronting proviral HIV infection.
Margolis DM. Margolis DM. Curr HIV/AIDS Rep. 2007 May;4(2):60-4. doi: 10.1007/s11904-007-0009-6. Curr HIV/AIDS Rep. 2007. PMID: 17547826 Review.
HIV "shock and kill" therapy: In need of revision.
Abner E, Jordan A. Abner E, et al. Antiviral Res. 2019 Jun;166:19-34. doi: 10.1016/j.antiviral.2019.03.008. Epub 2019 Mar 23. Antiviral Res. 2019. PMID: 30914265 Review.
Molecular mechanisms of HIV-1 proviral latency.
Bisgrove D, Lewinski M, Bushman F, Verdin E. Bisgrove D, et al. Expert Rev Anti Infect Ther. 2005 Oct;3(5):805-14. doi: 10.1586/14787210.3.5.805. Expert Rev Anti Infect Ther. 2005. PMID: 16207172 Review.
171 results